What is Amitriptyline?
Amitriptyline is the tricyclic antidepressant and a derivative of dibenzocycloheptadiene, used for treating the symptoms of depression. Amitriptyline is in a class of medications called tricyclic antidepressants. The drug relives from the symptoms through showing positive effect of the central nervous system through increasing stimulating the release of synaptic concentration of neurotransmitters such as serotonin and norepinephrine, which help in maintaining the overall mental balance. These antidepressant have sedative effects and thus can be used to treat the insomnia and migraine.
The market study is broken down, by Application (Depression, Migraine, Insomnia and Rheumatic diseases) and major geographies with country level break-up.
The market is highly competitive due to presence of generic drug manufacturers Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Novartis (Switzerland), Viatris Inc. (United States), F. Hoffmann-La Roche Ltd (Switzerland), Accord Healthcare (United Kingdom), Teva Pharmaceutical Industries Ltd. (Israel), Sun Pharmaceutical Industries Inc. (India), Par Pharmaceutical (United States), Dipharma Francis Srl (Italy), Torrent Pharmaceuticals Ltd. (India), Watson laboratories Inc. (United States), Egis Pharmaceuticals PLC (Hungary) and GLENMARK PHARMACEUTICALS LTD (India) are some of the key players that are part of study coverage.
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Amitriptyline market by Type, Application and Region.
On the basis of geography, the market of Amitriptyline has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Form, the sub-segment i.e. Tablet will boost the Amitriptyline market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution , the sub-segment i.e. Online Pharmacy will boost the Amitriptyline market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Dose, the sub-segment i.e. 10mg will boost the Amitriptyline market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In October 2017, the Zydus Cadila received approval from the United States Food and Drug Administration (USFDA) for the Amitriptyline hydrochloride tablets in the America. The Amitriptyline hydrochloride tablets are available in 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg strength.
Market Drivers
- Growing prevalence of migraine
- Availability of generic drugs at a cheaper cost
Opportunities
- Increasing cases of life-style related stress and depression
Restraints
- Side Effects of amitriptyline drugs
Key Target Audience
Generic drug manufacturers, Depression treatment drug companies, Research Institutes and Government
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.